
Safety and toxicology concerns remain one of the most persistent challenges in drug discovery. This is an exciting opportunity to join a multi-disciplinary team on a project to develop a comprehensive open source side effect resource for the scientific and pharmaceutical community, and provide structured and standardised training sets for AI/ML applications to improve early identification of safety liabilities.
You will harness modern machine learning techniques to extract data from a range of relevant resources, such as clinical trials, publications and drug labels. You will work closely with team members to ensure development of automated pipelines and effective integration into the ChEMBL database (https://www.ebi.ac.uk/chembl/) and Open Targets Platform (https://platform.opentargets.org/), to assist users in the selection of safe and efficacious drug targets.
The Chemical Biology Resources team at EMBL-EBI provides world-leading chemogenomics resources to the scientific community including ChEMBL, a database of quantitative small-molecule bioactivity data curated primarily from the scientific literature widely used to support drug discovery projects in industry and academia. The Safety 2.0 project is funded by Open Targets, a unique public-private partnership working to deliver experimental data and informatics resources that enable scientists to make more informed decisions about target selection for developing safer and more effective drugs. You will interact with safety scientists from Open Targets pharmaceutical partners MSD, Genentech, GSK, Pfizer, and Sanofi to understand requirements and how to help contribute to evaluating drug and target safety. You will be embedded at the world-leading EMBL-EBI, and will work collaboratively across the Chemical Biology Resources and Open Targets groups, benefitting from a range of multi-disciplinary expertise and technologies.
We are looking for an enthusiastic and talented scientific developer in the area of cheminformatics or bioinformatics with an interest in biomedical knowledge extraction to join the Open Targets Safety 2.0 project. You should enjoy addressing challenges in knowledge extraction and data standardisation, and want to contribute to open source code and resources.
The project will develop a new side effect resource for drug discovery based on the extraction of side effect data from a range of documents. Your role will focus on developing and implementing machine learning and data processing pipelines for the extraction of safety data. The position provides a real opportunity to make a significant impact on a critical problem in drug discovery for the many users of the Open Targets Platform and ChEMBL.
This position will be situated within the Chemical Biology Resources team (https://www.ebi.ac.uk/about/teams/chemical-biology-resources/). You will work closely with other Safety 2.0 project team members to ensure effective delivery of workpackages, and collaboratively with the Chemical Biology Resources team and Open Targets Core teams to ensure effective integration and longevity of pipelines and resources.
Contract length: 2 years
Salary: Grade 5 or 6, monthly salary from £3,452 or £3,861 after tax, plus generous benefits and financial allowances based on family circumstances. Excluding persona pension and insurance contributions.
Why join us
At EMBL-EBI you can apply your talent and passion to accelerate science and tackle some of humankind's greatest challenges. EMBL-EBI, part of the European Molecular Biology Laboratory, is a worldwide leader in the storage, analysis and dissemination of large biological datasets. We provide the global research community with access to publicly available databases and tools which are crucial for the advancement of healthcare, food security, and biodiversity.
We are located on the Wellcome Genome Campus, alongside other prominent research and biotech organisations, and surrounded by beautiful Cambridgeshire countryside. This is a highly collaborative and inclusive community where our employees enjoy a relaxed atmosphere. We are committed to ensuring our employees feel valued, supported and empowered to reach their professional potential. Watch this video to see how EMBL-EBI makes an impact.
For detailed information please visit our employee benefits page here.
Closing Date
11/10/2026

Founded in 1974, EMBL is Europe’s flagship laboratory for the life sciences – an intergovernmental organisation with more than 80 independent research groups covering the spectrum of molecular biology. It operates across six sites: Heidelberg, Barcelona, Hamburg, Grenoble, Rome and EMBL-EBI Hinxton. www.embl.org | www.embl.org/jobs
Our mission is to perform basic research in molecular biology; to offer vital services to scientists in the member states; to train scientists, students and visitors at all levels; to develop new instruments and methods in the life sciences and actively engage in technology transfer activities, and to integrate European life science research.
What we offer to you:
• Competitive salaries exempt from national taxes
• Range of benefits, from relocation support to family allowances
• Flexible and friendly working environment
• Certified training and continued development of your professional and personal skills